MADISON, Wis., Jan. 6, 2011 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI), the world's largest producer of human induced pluripotent stem (iPS) cell lines and tissue cells for drug discovery and safety, today announced that the company is scheduled to present at the 29th Annual JPMorgan Healthcare Conference at 7:30 a.m. PST, Thursday, January 13, at the Westin St. Francis Hotel in San Francisco. Robert Palay, chief executive officer of CDI, and Emile Nuwaysir, chief operating officer, will provide an overview of the company.
About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem cells and their ability to differentiate into any cell type for world-class drug development tools. In addition, it is the leader in iPS technology, the production of pluripotent stem cell lines from adult tissue. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human embryonic stem cell research at the University of Wisconsin-Madison, and Tactics II Ventures, a Wisconsin-based venture capital fund. CDI's facilities are located in Madison, Wisconsin.
SOURCE Cellular Dynamics International, Inc.